https://research.ouhsc.edu/news Parent Page: News id: 26727 Active Page: details id: 26917

News

OUHSC Research News – Monday, July 4, 2022


Published: Friday, July 1, 2022

OUHSC Research News – Monday, July 4, 2022

Notices and Reminders

SoonerTrack II Update

The Office of Research Administration (ORA) anticipates that the SoonerTrack II system will go live on July 11, 2022, replacing the SoonerTrack I system. Please be aware that beginning July 11, all SoonerTrack tickets in Pre-Submission status (tickets that have not yet reached ORA) MUST be resubmitted through the new SoonerTrack. Additionally, as of COB July 5, 2022, we will no longer be able to create any routing forms in the old SoonerTrack platform. This downtime will help us process any routing forms that have reached ORA prior to the go-live date so that you will not have to do business in two systems going forward. In the meanwhile, please check your current SoonerTrack tickets for any outstanding statuses that need to be completed/withdrawn prior to the go-live date.  If you have any questions, please contact soonertrackhelpdesk@ouhsc.edu.

SoonerTrack II Training Opportunities

Pre-scheduled SoonerTrack II training sessions are available at the following dates and times. All sessions are the same, so register for the one that best fits your schedule. Additional dates will be provided as needed (These sessions will be conducted via Zoom).  

  1. Wednesday, Jul 6, 2022, 9:00 AM - 10:00 AM

Register here

  1. Thursday, Jul 7, 2022, 2:00 PM - 3:00 PM

Register here

  1. Wednesday, Jul 13, 2022, 10:30 AM - 11:30 AM

Register here

  1. Wednesday, Jul 20, 2022, 1:30 PM - 2:30 PM

Register here

 

Workshops and Seminars

Harold Hamm Diabetes Center (HHDC) - Please mark your calendar for the 19th Annual Harold Hamm Diabetes Center Research Symposium. This in-person event will be held on Friday, November 11, 2022 at the Samis Education Center at Children’s Hospital in Oklahoma City. Deadline for abstracts will be announced in the coming weeks. Additional details will be posted on be posted here. Questions? Please email: Katie-Hoefling@ouhsc.edu

 

OUHSC Funding Opportunities

Presbyterian Health Foundation (PHF) Bridge Grant Program – Request For Applications

  • Cycle II PHF Bridge Grant Program Deadline: July 29, 2022

The primary objective of the PHF Bridge Grant Program is to provide funding to enhance OUHSC faculty competitiveness for extramural funding. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) have submitted an extramural application within the past 18 months that was scored but not funded, 2) are requesting over $750,000 in total direct costs and over $200,000 in total facilities and administration (F&A) costs; and 3) received a review that ranks applications  and provides critiques. 

IMPORTANT UPDATE: This program can now provide funding for up to $100,000 for one year. SALARY and FRINGE BENEFITS may be requested for the Principal Investigator(s) up to $25,000 in total (salary + fringe benefits = $25,000) with the remaining portion, $75,000, used to support the project costs. Guidelines and Application Form are attached or can be found here.  If you have any questions, please email  VPR@ouhsc.edu.

 

The Presbyterian Health Foundation and the Oklahoma Center for Therapeutic Sciences 2022 pilot award

The Presbyterian Health Foundation (PHF) and the Oklahoma Center for Therapeutic Sciences (CTS) are soliciting proposals for Investigator Seed Grant Awards in drug and probe discovery. The current RFA is focused on funding pilot projects that utilize the Drug and Target Discovery (DTD) High Throughput Screening (HTS) Facility and the Laboratory of Molecular Structure and Function (MSF). DTD can perform screens of its 7 chemical libraries (~100,000 compounds) using cell-based high-content imaging, as well as fluorescence, fluorescence polarization, TR-FRET, absorbance, and luminescence of cell-based assays or assays using purified components. DTD has cell culture facilities and a full suite of detection, robotic, and imaging equipment designed to facilitate work in microwell plates (96-or 384-well formats). The Facility will assist investigators in the design and development of screen assays that can use all currently available assay readouts and formats. Funding for pilot projects that utilize MSF will be focused on the use of its structure-guided software tools.

Documents for the pilot award announcement and a brochure describing the capabilities of CTS are attached.

If you have any questions, please contact Matthew Hart, Ph.D. at Matthew-J-Hart@ouhsc.edu

 

Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

  • Chinook Therapeutics is interested is collaboration to develop therapeutics targeting molecular drivers of kidney disease progression.  Approaches of interest include primary glomerular diseases, autoimmune-related renal disease, rare kidney disease indications, nephrolithiasis, PKD and renal transplant.  Novel genetic targets, drug-repurposing and novel approaches for targeted delivery are of interest.  Out of scope: congenital disease, diabetic nephropathy, acute injury and renal fibrosis.  Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 07/28)
  • Beckley Psytech is looking to collaborate on serotonin receptor agonists with therapeutic potential for neurological and psychiatric disorders.  Compounds with selectivity for 5HT2A are of highest interest, however compounds with additional selectivity for 5HT2B, Sigma 1, 5HT1D and 5HT7 will also be considered as will novel approaches for targeted delivery and compound scaffolds based on tryptamine, ergoline or phenethylamine.  Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 07/28)

 

NIH Notices 

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH Funding Opportunities

 

Other Funding Opportunities

Oklahoma Center for Adult Stem Cell Research (OCASCR)

Description: The overall goal of OCASCR is to help adult stem cell and regenerative medicine research thrive in Oklahoma and to serve as a trusted resource for public information on these topics. Grants are accepted for research, equipment, and travel/education, and other areas.

Application Deadline: September 20, 2022

Link to Full Announcement: http://www.ocascr.org/grants/

 

The International Center for Responsible Gaming - Small Grants for Research on Lottery Gambling

Description: The International Center for Responsible Gaming and the Hoosier Lottery are collaborating on a special initiative to encourage research on responsible gambling as it relates to lottery gambling. Research projects may include but are not limited to: 

  • Stand-alone research projects or a pilot project; 
  • Preliminary research in preparation for a large research project, such as a comprehensive literature review, or instrument development and testing; and 
  • Research tasks subsequent to a full research project, such as follow-up testing. 

Applicants may request up to $25,000 in direct costs and $5,000 in Facilities and Administration costs

Application Deadline: September 1, 2022

Link to Full Announcement: https://www.icrg.org/research-center/apply-icrg-funding

 

The Mark Foundation for Cancer Research - Endeavor Award and Informational Webinars

Description: The Mark Foundation Endeavor Awards support teams of scientists with diverse areas of expertise to address urgent problems in cancer research. The Endeavor Award program enables teams of three or more investigators to tackle challenges in cancer research that are too large for any single lab to address alone. Endeavor Awards are $3 million grants disbursed over a three-year term.

Informational Webinars: Endeavor Award website

LOI Submission Deadline: July 13, 2022

Link to Full Announcement: https://mailchi.mp/467458b9d14a/our-first-ever-newsletter-13500801?e=2d3e7329ff

 

The Oklahoma Center for the Advancement of Science and Technology (OCAST)  Notice of Funding Opportunity Announcements. OCAST has published a list of Funding Opportunity Announcements for FY 2022. The guidelines for 2022 have not been released yet. Next application submission period opens on August 15, 2022 and closes September 26, 2022. More information about the funding opportunity announcements and additional resources are available here: https://oklahoma.gov/ocast/ogx-overview/funding-opportunities.html.

 

The Cystic Fibrosis Foundation (CFF): Biological Basis for CF-Related Diabetes Program

Description: The intent of this request for applications is to solicit and fund projects that will improve our understanding of the biological basis for the development and progression of cystic fibrosis-related diabetes as well as to identify potential novel therapeutic strategies to manage and treat the disease. 

Application deadline: August 2, 2022

Link to Full Announcement: https://www.cff.org/researchers/biological-basis-cf-related-diabetes-program

 

The Cystic Fibrosis Foundation (CFF): Path to a Cure -- Collaborative Research Grant

Description: Path to a Cure: Collaborative Research Grants are intended to facilitate research that will contribute to the development of new therapies or therapeutic strategies to treat CF, with an emphasis on advancing CFTR gene repair and replacement approaches. Collaborations that bring new investigators and technologies into the CF research community will be given highest priority. Proposals must include preliminary data to justify support from the Cystic Fibrosis Foundation.

Application deadline: July 14, 2022

Link to Full Announcement: https://www.cff.org/researchers/path-cure-collaborative-research-grant

 

DoD FY22 Breast Cancer Research Program (BCRP)

  • Breakthrough Award Levels 1 and 2 II (BTA12-2)
  • Era of Hope Scholar Award II (EOHS-2)

Pre-Application (Letter of Intent): September 22, 2022
Application: October 6, 2022 

  • Breakthrough Award Level 3 II (BTA3-2)
  • Breakthrough Award Level 4 II (BTA4-2)
  • Innovator Award II (INNOV-2)
  • Transformative Breast Cancer Consortium Award II (TBCCA-2)

Pre-Application (Preproposal): August 3, 2022
Invited Application: November 2, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/bcrp

 

DoD FY22 Melanoma Research Program (MRP)

  • Idea Award (IA)

Pre-Application (Preproposal): July 8, 2022
Application: October 5, 2022

  • Melanoma Academy Scholar Award (MASA)
  • Mid-Career Accelerator Award (MCAA)
  • Team Science Award (TSA)
  • Focused Program Award – Rare Melanomas (FPA)

Pre-Application (Letter of Intent): September 14, 2022
Application: October 5, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/mrp

 

DoD FY22 Chronic Pain Management Research Program (CPMRP)

  • Clinical Exploration Award (CEA)
  • Investigator-Initiated Research Award (IIRA)
  • Translational Research Award (TRA)

Pre-Application (Preproposal): July 12, 2022
Application: October 13, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/cpmrp

 

DoD FY22 Lupus Research Program (LRP)

  • Idea Award (IA)
  • Impact Award (IPA)
  • Transformative Vision Award (TVA)

Pre-Application (Letter of Intent): August 16, 2022
Application: September 1, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/lrp

 

DoD FY22 Vision Research Program (VRP)

  • Clinical Trial Award (CTA)
  • Focused Translational Team Science Award (FTTSA)
  • Investigator-Initiated Research Award (IIRA)
  • Translational Research Award (TRA)

Pre-Application (Preproposal): July 15, 2022
Application: November 9, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/vrp

 

DoD FY22 Rare Cancers Research Program (RCRP)

  • Concept Award (CA)
  • Idea Development Award (IDA)
  • Resource and Community Development Award (RCDA)

Pre-Application (Letter of Intent): July 18, 2022
Application: August 29, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/rcrp

 

DoD FY22 Pancreatic Cancer Research Program (PCARP)

  • Idea Development Award (IDA)
  • Translational Research Partnership Award (TRPA)

Pre-Application (Preproposal): July 8, 2022 
Application: October 6, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/pcarp

 

DoD FY22 Prostate Cancer Research Program (PCRP)

  • Early Investigator Research Award (EIRA)
  • Physician Research Award (PRA)

Pre-Application (LOI): July 7, 2022

Application: July 28, 2022

Letters of Recommendation: August 2, 2022

  • Translational Science Award (TSA)
  • Health Disparity Research Award (HDRA)
  • Data Science Award (DSA)

Pre-Application (LOI): August 4, 2022

Application: August 25, 2022

  • Idea Development Award (IDA)

Pre-Application (LOI): July 7, 2022

Application: July 28, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/pcrp

 

DoD FY22 Peer Reviewed Cancer Research Program (PRCRP)

  • Behavioral Health Science Award (BHSA)
  • Career Development Award (CDA) – Fellow Option
  • Career Development Award (CDA) – Virtual Cancer Center Scholar Option
  • Translational Team Science Award (TTSA)

Pre-Application (Letter of Intent): July 12, 2022

Application: August 2, 2022

  • Convergent Science Cancer Consortium Development Award (CSCCDA)

Pre-Application (Letter of Intent): August 17

Application: September 7, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/prcrp

 

DoD FY22 Lung Cancer Research Program (LCRP)

  • Clinical Translational Research Partnership Award (CTRPA)        

Pre-Application (Letter of Intent): July 13, 2022

Letter of Intent is required.

Application: July 27, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/lcrp

 

MIT Solve/The Bill and Melinda Gates Foundation

Description: MIT Solve, in collaboration with the Bill & Melinda Gates Foundation, seeks solutions that will offer new ways of measuring primary health care performance improvement in low- and middle-income countries. Please visit the application website

Application deadline: August 9, 2022

Link to Full Announcement: https://solve.mit.edu/challenges/performance-improvement#challenge-subnav-offset

 

Documents to download